Brief: Qualigen Therapeutics Appoints Shishir Sinha To Lead Diagnostics Division
29/04/2022 14:43
April 29 (Reuters) - Qualigen Therapeutics Inc QLGN.O :
* QUALIGEN THERAPEUTICS APPOINTS SHISHIR SINHA TO LEAD
DIAGNOSTICS
DIVISION FOLLOWING PROMOTION TO SENIOR VICE PRESIDENT
Source text for Eikon: ID:nGNX6DGT73
Further company coverage: QLGN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aixcrypto Holdings
See all newsBrief: Aixcrypto - Enters Common Shares Purchase Agreement With Gold King Arthur Holding - SEC Filing
Chief Executive Officer And Director
Brief: Aixcrypto Holdings - Enters Note Purchase Agreement With CABG Acquisition Corp On May 12, 2026 - SEC Filing
Brief: Aixcrypto Holdings Reports First Quarter 2026 Results
AIxCrypto Q1 net loss widens as expenses rise